Brief: Moberg Pharma Q2 EBITDA Loss Widens To SEK 5.2 Mln

Moberg Pharma AB (publ)

13/08/2024 07:09

Aug 13 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q2 NET REVENUE SEK 4.1 MILLION (0)
    * Q2 EBITDA SEK -5.2 MILLION (-4.7)
    * TOPLINE RESULTS FROM NORTH AMERICAN PHASE 3 STUDY ARE
EXPECTED
IN JANUARY 2025

Source text for Eikon:  ID:nWkr1CsP9V 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))